Close X

We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

This two module course introduces you to the current unmet need in type 1 diabetes exploring registry data that indicates glycaemic control, hypoglycaemia, and diabetic ketoacidosis all continue to be suboptimally managed in many patients. While insulin remains the mainstay of therapy for people with type 1 diabetes, it is well known to lead to weight gain, an increased risk of hypoglycemia and high variability in glycaemic profiles. In the second module, we take a more in-depth look at the clinical trials that have investigated the use of adjunct therapies in the treatment of type 1 diabetes including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.

USER INSTRUCTIONS
Once enrolled on a course you can access the content in any order you wish, simply browse the course using the ‘CONTENT AND YOUR PROGRESS’ section on this page.

If at any time you need help finding the next step to complete just click the green tick in the bottom right of the screen for directions.

Course Content

2020 03 16